Trials / Enrolling By Invitation
Enrolling By InvitationNCT06823921
Cognitive Effects of Exercise in Parkinson's Disease
Effects of High-Intensity Interval Training (HIIT) on Cognitive Function and Quality of Life in Parkinson's Disease: A Pilot Clinical Trial
- Status
- Enrolling By Invitation
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Sule Tinaz · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
This pilot study will evaluate the short-term (3 months) and long-term (6 months) effectiveness of a high-intensity interval training (HIIT) program in improving cognitive function and self-efficacy in individuals with PD.
Detailed description
Participants will be assigned to either the HIIT group, which will engage in 3 classes per week, or a standard-of-care control group, which will include people who will continue their standard care and usual physical activities but do not plan on partaking in additional structured exercise interventions for 3 months (except for physical and occupational therapy if medically necessary). Cognitive functions will be measured using standardized tests (Stroop, Trail Making Test-B (TMT-B), verbal fluency (using letters F-A-S), and Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)), alongside assessing subjective ratings of daily cognitive function using the Neuro Quality of Life - Cognitive Function (Neuro-QoL CF) survey. Secondary outcomes will include self-efficacy measures, specifically regarding goal achievement, managing emotions and daily activities. We will also aim to obtain brain functional MRI (fMRI) and neuromelanin-sensitive MRI (NM-MRI) data from a subset of participants to measure the brain effects of HIIT as exploratory outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Exercise | HIIT will include aerobic, strength, and balance exercises and boxing |
Timeline
- Start date
- 2025-02-11
- Primary completion
- 2026-12-01
- Completion
- 2027-03-01
- First posted
- 2025-02-12
- Last updated
- 2026-02-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06823921. Inclusion in this directory is not an endorsement.